UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3406-3413

2017

Volltextzugriff (PDF)

Detection of Herpesviridae in whole blood by multiplex PCR DNA-based microarray analysis after hematopoietic stem cell transplantation

Journal of clinical microbiology, 2014-07, Vol.52 (7), p.2552-2556

2014

Volltextzugriff (PDF)

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial

Journal of antimicrobial chemotherapy, 2023-10, Vol.78 (10), p.2471-2480

2023

Volltextzugriff (PDF)

Legionnaire’s Disease in Haematology Patients: The Experience of 'Jules Bordet Institut ULB' in Brussels, Belgium

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S270-S270

2019

Volltextzugriff (PDF)

Is the « Old Jules Bordet Institute » the Source of Infections Observed Among Patients Hospitalized and Planned to Receive an Allogeneic/Autologous Hematopoietic Cells transplantations (HCT) in the Onco-Hematology Unit?

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S269-S270

2019

Volltextzugriff (PDF)

Febrile neutropenia: A critical review of the initial management

Critical reviews in oncology/hematology, 2011-06, Vol.78 (3), p.185-194

2011

Volltextzugriff (PDF)

An Aspergillus Myocardial Abscess Diagnosed by Echocardiography

Journal of the American Society of Echocardiography, 2008-10, Vol.21 (10), p.1177.e3-1177.e5

2008

Volltextzugriff (PDF)

Respiratory Syncytial Virus (RSV) Infection Treated by Ribavirin During an Allogeneic Haematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukaemia (AML)

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S226-S226

2019

Volltextzugriff (PDF)

Empiric therapy for febrile neutropenia: what are the choices?

Expert review of anti-infective therapy, 2007-06, Vol.5 (3), p.507-515

Aoun, Mickael

2007

Volltextzugriff (PDF)

The Continuing Changing Landscape of Cerebral Toxoplasmosis among Bone Marrow (BM)/Peripheral Blood Stem Cell (PBSC) Recipients

Clinical lymphoma, myeloma and leukemia, 2018-09, Vol.18, p.S302-S303

2018

Volltextzugriff (PDF)

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole

Mycoses, 2018-11, Vol.61 (11), p.868-876

2018

Volltextzugriff (PDF)

Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation

Transplantation, 2009-04, Vol.87 (8), p.1240-1245

2009

Volltextzugriff (PDF)

Multidrug-Resistant Pseudomonas aeruginosa Out-Break in the Haematological Unit of a 79-year Old Cancer Institute

Clinical lymphoma, myeloma and leukemia, 2018-09, Vol.18, p.S301-S302

2018

Volltextzugriff (PDF)

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC “Neutropenia, Infection and Myelosuppression” Study Group during the MASCC annual meeting held in Berlin on 27–29 June 2013

Supportive care in cancer, 2016-07, Vol.24 (7), p.2819-2826

2016

Volltextzugriff (PDF)

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3501-3501

2017

Volltextzugriff (PDF)

Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?

Supportive care in cancer, 2011-07, Vol.19 (7), p.1001-1008

2011

Volltextzugriff (PDF)

Hepatic Safety of Isavuconazole Compared With Voriconazole in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Complicated by Invasive Mold Disease: A Post-Hoc Analysis From the SECURE Study

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Volltextzugriff (PDF)

Intravenous Penciclovir for Treatment of Herpes Simplex Infections in Immunocompromised Patients: Results of a Multicenter, Acyclovir-Controlled Trial

Antimicrobial Agents and Chemotherapy, 1999-05, Vol.43 (5), p.1192-1197

1999

Volltextzugriff (PDF)

Pelvic actinomycosis presenting as ovarian neoplasia: a case report

Gynecological surgery, 2009-11, Vol.6 (4), p.385, Article 385

2009

Volltextzugriff (PDF)

1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S605-S605

2020

Volltextzugriff (PDF)

147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S203-S204

2020

Volltextzugriff (PDF)

Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection : A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial). Commentary

Clinical infectious diseases, 2007, Vol.44 (10), p.1289-1306

2007

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(14)
Infectious Diseases
(10)
Middle Aged
(8)
Male
(7)
Microbiology
(7)
Female
(6)
Adult
(5)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Pharmacology & Pharmacy
(5)
Immunocompromised Host
(4)
Oncology
(4)
Adolescent
(3)
Aged
(3)
Anti-Bacterial Agents - Therapeutic Use
(3)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(3)
Antifungal Agents - Administration & Dosage
(3)
Antifungal Agents - Therapeutic Use
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Detection of Herpesviridae in whole blood by multiplex PCR DNA-based microarray analysis after hematopoietic stem cell transplantation

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial

Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer

Legionnaire’s Disease in Haematology Patients: The Experience of 'Jules Bordet Institut ULB' in Brussels, Belgium

Is the « Old Jules Bordet Institute » the Source of Infections Observed Among Patients Hospitalized and Planned to Receive an Allogeneic/Autologous Hematopoietic Cells transplantations (HCT) in the Onco-Hematology Unit?

Febrile neutropenia: A critical review of the initial management

An Aspergillus Myocardial Abscess Diagnosed by Echocardiography

Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091)

Respiratory Syncytial Virus (RSV) Infection Treated by Ribavirin During an Allogeneic Haematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukaemia (AML)

Empiric therapy for febrile neutropenia: what are the choices?

The Continuing Changing Landscape of Cerebral Toxoplasmosis among Bone Marrow (BM)/Peripheral Blood Stem Cell (PBSC) Recipients

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole

Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation

Multidrug-Resistant Pseudomonas aeruginosa Out-Break in the Haematological Unit of a 79-year Old Cancer Institute

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC “Neutropenia, Infection and Myelosuppression” Study Group during the MASCC annual meeting held in Berlin on 27–29 June 2013

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?

149. Immunogenicity, Safety, and Post-hoc Efficacy Assessment of the Adjuvanted Recombinant Zoster Vaccine in Adults with Hematologic Malignancies: A Phase 3, Randomized Clinical Trial

Hepatic Safety of Isavuconazole Compared With Voriconazole in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Complicated by Invasive Mold Disease: A Post-Hoc Analysis From the SECURE Study

Intravenous Penciclovir for Treatment of Herpes Simplex Infections in Immunocompromised Patients: Results of a Multicenter, Acyclovir-Controlled Trial

Pelvic actinomycosis presenting as ovarian neoplasia: a case report

1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial

147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection : A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial). Commentary

Suchergebnisse filtern